Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

NCT00844064

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +22 more
Locations
  • Universitätsmedizin Berlin Charité Berlin, Germany
  • Universitätsklinik und Poliklinik für Innere Medizin I Halle, Germany
  • Hautklinik der Ruprecht-Karls-Universität Heidelberg Heidelberg, Germany
  • Universitätsklinikum Schleswig-Holstein Kiel, Germany
View Trial Details
Completed

PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma

NCT02492815

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution Boston, Massachusetts, United States
  • Outcome Sciences Inc Dba Outcome Boston, Massachusetts, United States
  • Local Institution Linz, Austria
  • Local Institution Brussels, Belgium
View all 17 locations
View Trial Details
Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

NCT00121225

Conditions
Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +20 more
Locations
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Fox Chase Cancer Center Rockledge, Pennsylvania, United States
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
View Trial Details
Completed

Melanoma Image Analysis Algorithm (MIAA) Validation Study

NCT02612168

Conditions
Disease, Malignant Melanoma, Melanoma, +13 more
Locations
  • Royal Devon and Exeter Exeter, Devon, United Kingdom
  • Whipps Corss Hospital Leytonstone, London, United Kingdom
  • Royal Stoke University Hospital Stoke, Staffordshire, United Kingdom
  • Russells Hall Hospital Dudley, West Midlands, United Kingdom
View Trial Details
Completed

A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])

NCT03139513

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Centre Hospitalier d'Albi Albi, France
  • Hopital Prive D Antony; Dermatologie Antony, France
  • Chic Cote Basque Bayonne; Medecine II Bayonne, France
  • CHU Besançon - Hôpital Jean Minjoz Besançon, France
View all 33 locations
View Trial Details

Related conditions